# SYNRIBO
> **NDA203585** · New Drug Application · Sponsor: TEVA PHARMS INTL · Approved 2012-10-26
## Drug
- **FDA Application Number:** NDA203585
- **Application type:** New Drug Application
- **Brand name:** SYNRIBO
- **Generic name:** Omacetaxine Mepesuccinate
- **Active ingredients:** OMACETAXINE MEPESUCCINATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS INTL
- **First approval:** 2012-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203585)
---
*AI Analytics · CC0 1.0*